High-Dose Dexmedetomidine for Sedation in the Intensive Care Unit: An Evaluation of Clinical Efficacy and Safety

Annals of Pharmacotherapy

Volumn 45, Issue 6, 2011, Pages 740-747

  Jones, G Morgan ^a   Murphy, Claire V ^b   Gerlach, Anthony T ^b   Goodman, Erin M ^c   Pell, Lindsay J ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c Clinical Pharmacist   (United States)

Author keywords

Dexmedetomidine; Intensive care unit; Sedation

Indexed keywords

DEXMEDETOMIDINE;

ADULT; ARTICLE; BRADYCARDIA; CLINICAL EVALUATION; CONTROLLED STUDY; DATA ANALYSIS; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLE; SEDATION;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADULT; AGED; BRADYCARDIA; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTENSION; INTENSIVE CARE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79958783407     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P726     Document Type: Article

References (21)

1. Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD. Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 2009;37:3031-9. DOI 10.1097/CCM.0b013e3181b02eff
2. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-41. DOI 10.1097/00003246-200201000-00020
3. Rhoney DH, Murry KR. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med 2003;18:139-45. DOI 10.1177/0885066603018003003
4. Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother 2009;43:2064-2074. DOI 10.1345/aph.1M310
5. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009;301:489-99. DOI 10.1001/jama.2009.56
6. Product information Precedex (dexmedetomidine). Lake Forrest, IL: Hospira, September 2010.
7. Wunsch H, Kahn JM, Kramer AA, et al. Dexmedetomidine in the care of critically ill patients from 2001 to 2007: an observational cohort study. Anesthesiology 2010;113:386-94. DOI 10.1097/ALN.0b013e3181e74116
8. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007;41:245-252. DOI 10.1345/aph.1H314
9. Gerlach AT, Dasta JF, Steinberg S, Martin LC, Cook CH. A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients. J Crit Care 2009;24:568-74. DOI 10.1016/j.jcrc.2009.05.015
10. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 2010;36:926-39. DOI 10.1007/s00134-010-1877-6
11. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298:2644-53. DOI 10.1001/jama.298.22.2644
12. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002;166:1338-44. DOI 10.1164/rccm.2107138
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29. DOI 10.1097/00003246-198608000-00028
14. Ruokonen E, Parviainen I, Jakob SM, et al. Dexmedetomidine versus propofol/ midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009;35:282-90. DOI 10.1007/s00134-008-1296-0
15. Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 2003;29:201-7.
16. Devabhakthuni S, Pajouman M, Williams C, Watson K, Kufera J, Stein D. Evaluation of dexmedetomidine: safety and clinical outcomes in critically ill trauma patients. Crit Care Med 2010;38(12 suppl):A252.
17. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003;17:576-84. DOI 10.1016/S1053-0770(03)00200-3
18. Ickeringill M, Shehabi Y, Adamson H, Ruettimann U. Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy. Anaesth Intensive Care 2004;32:741-5.
19. Biccard BM, Goga S, de Beurs J. Dexmedetomidine and cardiac protection for non-cardiac surgery: a meta-analysis of randomised controlled trials. Anaesthesia 2008;63:4-14. DOI 10.1111/j.1365-2044.2007.05306.x
20. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94. DOI 10.1097/00000542-200008000-00016
21. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002;88:669-75. DOI 10.1093/bja/88.5.669